Found 4 matching trials
Perioperative Chemotherapy Plus Trastuzumab Plus Toripalimab in HER2 Positive Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma PHASE2 This study is a prospective, single arm, multi-center phase II clinical tri...
Show More Location
The First Affiliated Hospital, College of Medicine, Zhejiang University
Learn More & Join Trial
Toripalimab Plus FLOT in Locally Advanced Gastric Cancer PHASE2 Neoadjuvant chemoimmunotherapy for locally advanced gastric and gastroesoph...
Show More Location
Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital
Learn More & Join Trial
A Prospective, Single Center Clinical Study of Toripalimab Combined With FLOT Regimen for Perioperative Treatment of PD-L1 Positive Locally Advanced Resectable Gastric Cancer or Gastroesophageal Junction Adenocarcinoma (GEJ) PHASE2 In this study, patients with PD-L1 positive locally advanced patients with ...
Show More Location
First Hospital of Jilin University
Learn More & Join Trial
Toripalimab Combined With FLOT Neoadjuvant Chemotherapy in Patients With Resectable Gastric Cancer PHASE2 Gastric cancer is one of the most common malignant tumors of the digestive ...
Show More Location
Tianjin Medical University Cancer Institute & Hospital
Learn More & Join Trial